Patent · US Active

Engineered glucosyltransferases

US10301604B2 · kind B2 · utility

6Cited by

16References

20Claims

0Family size

Assignee

E.I. DU PONT DE NEMOURS AND COMPANY · US

Inventors

Yougen Li · Pennington, US
Mark S. Payne · Wilmington, US
Jared B. Parker · Elkton, US
Slavko Kralj · Copenhagen, DK
Veli Alkan · Palo Alto, US
Richard R. Bott · Burlingame, US
Robert DiCosimo · Chadds Ford, US
Qiong Cheng · Wilmington, US
Ellen D. Semke · Newark, US
Susan Marie Hennessey · Avondale, US

Key dates

Filing date	Sep 13, 2017
Grant date	May 28, 2019
Priority date	—
Expiry date	Sep 13, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12P19/18
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein are glucosyltransferases with modified amino acid sequences. Such engineered enzymes exhibit improved alpha-glucan product yields and/or lower leucrose yields, for example. Further disclosed are reactions and methods in which engineered glucosyltransferases are used to produce alpha-glucan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.